These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1569450)

  • 61. The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation.
    Frassoni F; Scarpati D; Bacigalupo A; Vitale V; Corvo R; Miceli S; Gualandi F; Occhini D; Clavio M; van Lint MT
    Br J Haematol; 1989 Oct; 73(2):211-6. PubMed ID: 2684259
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial.
    Wagner JE; Donnenberg AD; Noga SJ; Cremo CA; Gao IK; Yin HJ; Vogelsang GB; Rowley S; Saral R; Santos GW
    Blood; 1988 Oct; 72(4):1168-76. PubMed ID: 3048436
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party.
    Barrett AJ; Locatelli F; Treleaven JG; Gratwohl A; Szydło R; Zwaan FE
    Br J Haematol; 1991 Dec; 79(4):567-74. PubMed ID: 1772778
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
    Ringdén O; Remberger M; Aschan J; Lungman P; Lönnqvist B; Markling L
    Transplantation; 1994 Oct; 58(8):887-91. PubMed ID: 7940731
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is there any future for T-cell depleted bone marrow transplantation in chronic myeloid leukaemia?
    Martelli MF; Aversa F
    Leuk Lymphoma; 1993; 11 Suppl 1():205-7. PubMed ID: 8251897
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bronchiolitis obliterans after bone marrow transplantation: the effect of preconditioning.
    Paz HL; Crilley P; Topolsky DL; Coll WX; Patchefsky A; Brodsky I
    Respiration; 1993; 60(2):109-14. PubMed ID: 8341852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation.
    Payne L; Chan CK; Fyles G; Hyland RH; Bafundi P; Yeung M; Messner H
    Chest; 1993 Jul; 104(1):114-8. PubMed ID: 8325051
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation.
    Nevill TJ; Fung HC; Shepherd JD; Horsman DE; Nantel SH; Klingemann HG; Forrest DL; Toze CL; Sutherland HJ; Hogge DE; Naiman SC; Le A; Brockington DA; Barnett MJ
    Blood; 1998 Sep; 92(6):1910-7. PubMed ID: 9731047
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.
    Gluckman E; Horowitz MM; Champlin RE; Hows JM; Bacigalupo A; Biggs JC; Camitta BM; Gale RP; Gordon-Smith EC; Marmont AM
    Blood; 1992 Jan; 79(1):269-75. PubMed ID: 1728315
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.
    Goldman JM; Gale RP; Horowitz MM; Biggs JC; Champlin RE; Gluckman E; Hoffmann RG; Jacobsen SJ; Marmont AM; McGlave PB
    Ann Intern Med; 1988 Jun; 108(6):806-14. PubMed ID: 3285744
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
    Snyder DS; Negrin RS; O'Donnell MR; Chao NJ; Amylon MD; Long GD; Nademanee AP; Stein AS; Parker PM; Smith EP
    Blood; 1994 Sep; 84(5):1672-9. PubMed ID: 8068956
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation.
    de Witte T; Hoogenhout J; de Pauw B; Holdrinet R; Janssen J; Wessels J; van Daal W; Hustinx T; Haanen C
    Blood; 1986 May; 67(5):1302-8. PubMed ID: 3516253
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevention of graft failure by cyclosporine in rats receiving lymphocyte-depleted MHC-mismatched bone marrow.
    Wagner JE
    Transplantation; 1992 Mar; 53(3):624-8. PubMed ID: 1549856
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation].
    Merino A; Urbano-Ispizua A; Marín P; Besson I; Carreras E; Sierra J; Salgado C; Rovira M; Grañena A; Montserrat E
    Sangre (Barc); 1993 Oct; 38(5):359-64. PubMed ID: 8140496
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: update of a prospective randomized study.
    Gratwohl A; Hermans J; Biezen AV; Arcese W; de Witte T; Debusscher L; Ernst P; Ferrant A; Frassoni F; Gahrton G
    Leuk Lymphoma; 1993; 11 Suppl 1():227-31. PubMed ID: 8251901
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Favourable outcome of patients older than 40 years of age after transplantation with marrow grafts depleted of lymphocytes by counterflow centrifugation.
    Bär BM; De Witte T; Schattenberg A; Boezeman J; Hoogenhout J
    Br J Haematol; 1990 Jan; 74(1):53-60. PubMed ID: 2310697
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission.
    McGlave PB; Haake RJ; Bostrom BC; Brunning R; Hurd DD; Kim TH; Nesbit ME; Vercellotti GM; Weisdorf D; Woods WG
    Blood; 1988 Nov; 72(5):1512-7. PubMed ID: 3052625
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of IgA deficiency after bone marrow transplantation. The influence of acute and chronic graft-versus-host disease.
    Abedi MR; Hammarström L; Ringdén O; Smith CI
    Transplantation; 1990 Sep; 50(3):415-21. PubMed ID: 2402790
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.
    Clift RA; Buckner CD; Thomas ED; Bryant E; Anasetti C; Bensinger WI; Bowden R; Deeg HJ; Doney KC; Fisher LD
    Blood; 1994 Dec; 84(12):4368-73. PubMed ID: 7527674
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.
    Darmstadt GL; Donnenberg AD; Vogelsang GB; Farmer ER; Horn TD
    J Invest Dermatol; 1992 Oct; 99(4):397-402. PubMed ID: 1401996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.